drugset / Trial / NCT05670379
Assessment of Safety, Tolerability and Drug Levels of Exenatide Implant
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the safety, tolerability and drug levels of an exenatide implant administered subcutaneously.
Timeline
- Start
- 2024-12-20
- Primary completion
- 2025-08-21
- Completion
- 2025-08-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Exenatide | Peptide | 52 ug | Subcutaneous |
| Comparator | Exenatide | Peptide | 2 mg | Subcutaneous |
| Comparator | Semaglutide | Peptide | 1 mg | Subcutaneous |